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ABSTRACT 
Government and policy makers want to engage the public in a dialogue about the conduct 
and consequences of science and increasingly seek to actively involve citizens in decision 
making processes. Implicit in this thinking is that greater transparency and public 
inclusion will help dispel fears associated with new scientific advancements, foster 
greater public trust in those accountable and ultimately increase the acceptability of new 
technologies. Less understood, however, are public perceptions about such high level 
involvement in science and how these map onto public trust and attitudes within a diverse 
population.   
  
This paper uses the concept of ‘public efficacy’ - the extent to which people believe that 
the public might be able to affect the course of decision making -  to explore differences 
in trust, attentiveness and attitudes towards modern genetic science. Using nationally 
representative data from the 2003 British Social Attitudes Survey, we begin by 
examining the characteristics of those who have a positive belief about public 
involvement in this area of scientific inquiry. We then focus on how this belief maps on 
to indicators of public trust in key stakeholder groups, including the government and 
genetic scientists. Finally, we consider the relationship between public efficacy and trust 
and attitudes towards different applications of genetic technology.  
  
Our findings run contrary to assumptions that public involvement in science will foster 
greater trust and lead to a climate of greater acceptance for genetic technology. A belief 
in public efficacy does not uniformly equate with more trusting attitudes towards  
stakeholders but is associated with less trust in government rules.  Whereas trust is 
positively correlated with more permissive attitudes about technologies such as cloning 
and gene therapy, people who have a belief in high level public involvement are less 
likely to think that these technologies should be allowed than those who do not. 
Keywords: public efficacy, trust, genetic science, attitudes, engagement 
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1. SCIENCE AND THE PUBLIC 
Advancements in the biomedical sciences, such as the decoding of the human genome, 
pave the way for technologies that have potentially profound impacts on human health 
and the environment.  These same technologies bring to the fore ethical, social and 
political challenges.  In this context of rapid scientific advancement, the relationship 
between science and its public has come under scrutiny in three key respects:  
  Firstly, surveys of public attitudes to science reveal that general optimism is 
often accompanied by public scepticism or concern (MORI, 2005).  Although the British 
public are generally supportive of science, with a majority agreeing that science and 
technology make our lives ‘healthier, easier and more comfortable’ (Office of Science 
and Technology, 2000: p.22) and that ‘the benefits of science and technology are greater 
than any harmful effects it may have’ (European Commission, 2005: p.53), the same data 
highlight accompanying reservations. The 2005 Eurobarometer survey on public attitudes 
to science and technology showed that in the UK 14 percent of the UK public felt that 
science and technology could sort out any problem compared with an EU average of 21 
percent (European Commission, 2005) . More than half of UK citizens concurred with 
the view that ‘science and technology are responsible for most of the environmental 
problems we have today’ (MORI, 2005) and there is often general unease at the speed 
with which scientific developments often outpace public awareness and consultation 
(House of Lords, 2000).  
Secondly, there is evidence that a sizeable proportion of the public perceive 
themselves to be disconnected or disengaged from science.  A recent UK study found that 
only 40 percent consider themselves well-informed about science and confusion exists 
about what the public consultation process actually involves (MORI, 2005).  In a survey 
of European member states, only 1 in 10 citizens felt ‘very well informed’ about new 
scientific discoveries in 2005 (European Commission, 2005: p.17). The same survey 
reported that although 30 percent were very interested in new scientific discoveries, 
inventions and technologies, this was 8 percent less than in 1992.  Of those that expressed 
disinterest in science, the most commonly cited reason was a ‘lack of understanding’, 
with a ‘lack of concern’ coming a close second.   A number of empirical studies report 
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low levels of scientific literacy among the public based on their comprehension of basic 
scientific ‘facts’ or scientific reasoning (Miller, 1983).  Such indicators of public 
understanding of science have been found to correlate with reported interest and with a 
range of demographic variables which show that scientific interest, awareness and 
knowledge are not uniformly distributed among the public but correlate with age, gender, 
education and social class (Durant, Evans & Thomas, 1992; Gaskell, Allum & Stares, 
2003).  The identification of a discrepancy between the public’s expressed interest and 
knowledge and that of experts represents a particular perspective on the public 
understanding of science that is often considered to be discredited, although interest in 
the relationship between ‘scientific knowledge’ and attitudes continues (Sturgis & Allum, 
2004). The essence of such a deficit model is that the public is passive, ignorant, sceptical 
or worried, ‘because it does not understand the science’ (Irwin & Michael, 2003:14). 
Within a constructivist view of public knowledge that has developed in response 
to this ‘deficit’ model, there is now considerable evidence for the validity of other 
variants of lay knowledge (Irwin & Wynne, 1996; Yearley, 2000).  Notions of lay 
expertise and knowledge and a focus upon contextualised public understandings of 
science are thus now as widespread as those of a deficit in public understandings were 
twenty five years ago. However the deficit model undoubtedly remains influential in 
shaping views of publics and of ways of engaging with them (Michael, 2002; Levitt, 
Weiner & Goodacre, 2005, Petts & Brooks, 2006) 
A third dimension of the relationship between science and the public that has 
received considerable attention is the low levels of trust and confidence that publics often 
have in some scientific experts and the institutions that develop science based policy and 
practice..  This ‘crisis in confidence’ (House of Lords, 2000) is widely (though some 
would say mistakenly – see Marris, Wynne & Simmons et al., 2001; Wynne, 2001) 
attributed to several well-publicised controversies over the last two decades  - most 
notably that surrounding BSE (Jasanoff, 1997), and continuing today, for example, 
through public disquiet about the MMR vaccination (Hobson-West, 2003). This disquiet 
is echoed in opinion surveys where members of the public are cynical about the 
motivations of scientific researchers (Office of Science & Technology, 2000).  It is 
notable that in surveys there is more evidence of trust being differentially attributed to, 
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for example, national government, variously affiliated scientists, politicians, and the 
media, than there is for changing levels of trust over time (Worcester, 2001; Poortinga 
and Pidgeon, 2004; MORI, 2005).      
Certainly the restoration or maintenance of trust is seen as vital to facilitate 
scientific innovation; a lack of trust is thought to contribute to public resistance, which in 
turn may threaten future science and technology development (House of Lords, 2000).   
Trust is believed to reduce social complexity (Earle & Cvetkovich, 1995), thus being 
particularly valuable in affording the development of scientific technologies that 
challenge values, raise social and ethical questions or are more obviously characterised 
by long-term uncertainties (Siegriest & Cvetkovich, 2000; Poortinga & Pidgeon, 2003a). 
In contrast, a  lack of trust can serve to intensify public concerns, trigger secondary 
impacts such as the stigmatisation of places, products or processes (Flynn, Slovic & 
Kunreuther, 2001) or render risk prevention or reassurance messages less effective 
(Bennett & Calman, 1999). In short, building trust is seen to lessen the significance of 
differences between expert and lay perspectives and to provide a means to increase the 
acceptability of expert decision making.  Qualitative work has also been influential in 
drawing attention to the central importance of trust in governance around science (Grove-
White, R., Macnaghten & Meyer et al., 1997;  Marris, Wynne & Simmons et al., 2001) 
although rather than locating a deficit of trust within the public, the focus here is upon the 
required re-orientation of policy institutions. 
 
2. ENGAGING THE PUBLIC 
Faced with the difficulties of promoting and advancing science in a climate of public 
scepticism, disconnection and apparent distrust, the attention of policy makers has 
increasingly focused on developing what the Prime Minister in 2002 termed a ‘robust and 
engaging dialogue’ between scientists and the public (Prime Minister, 2002).  This 
imperative for dialogue ostensibly signals a move away from the traditional model of 
science communication where the communication of scientific ‘facts’ is essentially top-
down from the scientific community to the lay public and has been recast as a two-way 
dynamic exchange to which each party brings, not only their existing knowledge, but a 
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host of background characteristics, beliefs and life experiences (House of Lords, 2000; 
Department of Trade & Industry, 2001). Informing the public remains an important goal 
in order to facilitate informed debate and decision making, but alongside this it is 
recognised that scientists and policy makers have much to learn from attending to public 
opinions, attitudes and values (MORI, 2000; Worcester, 2001).  Assent to the necessity, if 
not the value, of public consultation is now widespread to the extent that Harrison & 
Mort (1998) suggest that “being in favour of public consultation (..) is rather like being 
against sin; at a rhetorical level, it is hard to find disagreement’ (p. 61).   
The involvement of publics in science can, however, serve the more instrumental 
purpose of increasing trust in decision makers and, more contentiously, the acceptability 
of the decisions themselves. Wilsden and Willis (2004) note how governments may want 
to engage with the public in order to build trust in science and to be seen dealing with 
issues in a competent way, heading off any potentially embarrassing or unmanageable 
public alienation on risk issues.   Put another way, communication with the public can be 
an effective means to reach desired policy ends (Fioriono, 1990) – namely, to facilitate 
greater public acceptance of science and its licence to practise.   
Public participation can, and has, taken many forms, from the informal sharing of 
information to organised events such as consensus conferences or citizens panels, through 
to what has been termed a ‘high level of active public dialogue’ (Department for 
Environment, Food & Rural Affairs, 2001) where substantive public input is sought at 
policy decision making level. Public involvement at this stage is argued to improve the 
quality of decision making, particularly when it occurs ‘upstream’, as the issues emerge  
(Wilsden & Willis, 2004) although evaluation of the difference that dialogue makes to 
outcomes as well as to processes is rarely conducted (Rowe & Frewer, 2000; Rowe, 
Horlick-Jones & Walls et al., 2005). Still less is known about the way in which publics 
view their participation and involvement.  It is to this question and the implications of 
public involvement for building trust and impacting on public attitudes, that we hitherto 
focus our attention.  
 
3. PUBLIC PERCEPTIONS ABOUT ENGAGEMENT 
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Although, as noted above, the case has been made for public involvement in science, it is 
unclear how the public view participation and dialogue and their potential role within 
such processes. Still less is known about how such beliefs may map on to other beliefs 
and the background characteristics of publics. A greater understanding of this may be 
helpful particularly in formal participation initiatives where demands upon the public to 
acquire and assimilate information may be high, as well as requiring considerable 
investments of time. 
 When questioned, members of the public (like experts) appear to endorse the 
principle of their greater involvement and consultation in science, whilst at the same time 
conceding they know little or nothing about it (MORI, 2005). The 2005 Eurobarometer 
survey found a majority of EU citizens agreed that the public is not sufficiently involved 
in science and that  ‘scientists put too little effort into informing the public about their 
work’  and should ‘listen more to what the public think’ (European Commission, 2005). 
Coupled with widespread support for more information and debate on scientific issues 
(MORI, 2005), this could be construed as a ‘latent interest’ for science among the public.  
However, a large disparity exists between general agreement that public input is a ‘good 
thing’ and some formal indicators of engagement with science drawn from survey work.  
Only 1 in 10 people surveyed in the EU report talking to friends about science and 
technology and the proportion who read about it is low at 19 percent (European 
Commission, 2005). More than three-quarters of people in this survey had never actively 
participated in science, for example, by signing a petition or attending a meeting about an 
issue they felt strongly about and, in the UK, public awareness of organised science 
events is very low (MORI, 2005). This is significant because research suggests that it is 
these more active kinds of civic participation that are most fundamental for building trust 
between members of a local community, as well as between the public and institutions 
who govern them (Duffy, 2004; Veenstra, 2000).  It is, however, debateable whether this 
is part of a wider decline in public participation of this type, with British survey data 
showing little evidence of a fall in political participation or willingness to engage in 
organised action between 1983 and 2001 (Bromley, Curtice & Seyd, 2001). 
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 Low levels of active public engagement with science are likely to stem in part 
from public perceptions of its value. Approximately 3 in 10 UK citizens surveyed in the 
Eurobarometer agreed with the proposition ‘it is not important for me to be involved in 
decisions about science and technology’. Of those who disagreed with the statement, a 
disproportionate number were from higher socio-economic groups, were younger and 
more knowledgeable about science. Qualitative research finds that public consultation 
exercises tend to be viewed by people as unrepresentative and the preserve of those who 
have strong opinions (MORI, 2005), falling short of attracting the widespread, socially 
inclusive support often considered the pre-requisite for making balanced and effective 
decisions and for building public trust. 
  Importantly, people may doubt the potential of the public to make a difference.   
In 2005, half of the surveyed UK public felt they personally had no influence on decision 
making in science and scientific research and 2 in 10 were of the opinion that the 
government fails to listen or act on the outcome of any public consultation on science 
(MORI, 2005).  This issue has been empirically investigated with respect to the British 
political system where the concept of ‘political efficacy’ was used as an indicator of the 
confidence people had in their own ability to articulate demands and in the system to 
respond to them effectively (Bromley, Curtice & Seyd, 2001). The analysis found that 
political efficacy was associated with greater trust in government to put the needs of the 
nation first and those with higher levels of efficacy were more likely to engage in voting 
behaviour or take some form of civic action.  Marris, Wynne & Simmons et al., (2001) 
highlight the notion of agency and hypothesise that lack of agency may obscure the 
expression of concern.   More recently, Simmons and Burchell (2005) have noted that the 
motivations of key actors to participate are crucial, but are often poorly understood. 
Focusing on one such group – service users – they explore the extent to which users are 
motivated by individualistic or collectivistic concerns and suggest that both should be 
incorporated into the design of effective public participation initiatives.   
 
3. MODERN GENETIC SCIENCE – AN EXEMPLAR 
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This paper will conduct an exploratory analysis using the concept of efficacy as it relates 
to perceptions about public involvement in a particular area of scientific inquiry – 
modern genetic science.  Using data from the 2003 British Social Attitudes Survey, we 
investigate how a belief in the effectiveness of public involvement in decision making 
about genetic science relates to trust in decision makers and attitudes towards new 
genetic technologies. A relatively new and rapidly advancing field of scientific inquiry, 
genomics has many characteristics that make it a particularly suitable domain within 
which to investigate the mutually reinforcing relationships often held to exist between 
public efficacy, trust and attitudes.  
Firstly, the term ‘genomics’ encompasses a range of new genetic applications 
which will have profound implications for human health and the environment. The long-
term outcomes of genetic technologies are, however, characterised by considerable 
uncertainty and controversy, with many scientific, legal, social and ethical questions as 
yet unanswered.  In recent years, a number of biotechnology issues have been brought to 
the public’s attention through widespread media coverage (Gaskell, Allum & Bauer et 
al., 2003), the most longstanding one being GM crops and foods (Vidal, 2003), but more 
recently human cloning and so-called ‘saviour siblings’ (Marsh, 2003). 
Secondly, genomics is an area where public opinion is visibly nuanced and fluid.  
In general, public attitudes to genetic science can be characterised as sceptical, but not 
overwhelmingly hostile. However, public opinion differentiates between different 
technologies according to their outcome.  Majority support is found for applications 
where there are clear medical benefits for the diagnosis and treatment of human disease 
(MORI, 2005; Sturgis, Cooper, Fife-Schaw et al., 2004; Gaskell, Allum & Stares, 2003; 
MORI, 1999) but opinion becomes markedly more oppositional if the same technology is 
used to different ends, for example, to clone human cells or decide whether or not to 
continue a pregnancy (Human Genetics Commission, 2001; MORI, 2003).  It is the 
‘green-biotechnologies’ that have attracted most public anxiety over the last two decades, 
with the genetic modification of plants widely perceived as risky and of limited 
usefulness (Gaskell, Allum & Bauer et al., 2003).  However, over the last five years, a 
number of surveys have reported less outright public hostility towards GM crops and 
foods which could be indicative of greater ambivalence towards these technologies 
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(Sturgis, Cooper, Fife-Schaw et al., 2004; MORI, 2005; Horlick-Jones, Walls & Rowe et 
al., 2004).   Mirroring the picture for science as a whole, surveys also show that 
government institutions as well as those associated with the biotechnology industry are 
among those commanding the least confidence about GM (Gaskell, Allum & Stares, 
2003) and that less than half of Europeans agree that government and industry  are ‘doing 
a good job for society’ (Gaskell, Allum & Bauer et al., 2003). 
Finally, genetic science is an area that exemplifies the governments’ commitment 
to public engagement but where the complexity and uncertainty of many of the processes 
and outcomes associated with new genetic technologies arguably render engagement of 
the general public difficult.  To date, the most ambitious exercise has been the 
government sponsored ‘GM Nation? public debate’ with the British people in 2002.   
This debate was explicit in its aim to ‘inform decision making’ (Department of Trade & 
Industry, 2003: p.11) and incorporated several strands of public involvement, including 
discussion workshops and on-line completion of a short survey (see Horlick-Jones, Walls 
& Rowe et al., 2004; Gaskell, 2004).  The conduct of the debate has not been without its 
critics, among them Wilsden and Willis (2004) argue that it was a prime example of an 
instrumentally motivated exercise - ‘ministers wanted to be seen as doing the right thing 
in order to build trust in their handling of the issue and perhaps to move towards greater 
acceptance of the technology’ (p.39). Arguably, it failed in its remit to inform decision 
making because it took place ‘downstream’, that is, once political, economic and 
organisational commitments were already in place.  People expressed little confidence in 
their own power to influence decisions about GM, although among the British public 
there remains a high level of support for government consultation on GM food (Poortinga 
& Pidgeon, 2003b).   
The aims and hypotheses of this study are three fold.  Firstly we investigate public 
perceptions of involvement in modern genetic science using an indicator of public 
efficacy (BPE) derived from existing survey data.  We examine what, if any, background 
characteristics distinguish the efficacious public from those who reject the notion of 
public involvement using key demographic indicators as well as values and attentiveness 
in relation to this area of science.  Secondly, we investigate the relationship between our 
indicator of public efficacy and trust in key stakeholder groups for modern genetic 
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science. Our overview of the literature and policy discourse leads us to hypothesise that 
any association between public efficacy and trust will be a positive one, with those 
expressing most confidence about public participation having more trusting attitudes than 
those who do not.  Finally we empirically examine how public efficacy and trust impact 
on attitudes towards three distinct genetic technologies.  We test the assumption that 
more positive attitudes towards genetic technologies will be found among those who do 
not reject high level public involvement in this area of science and who express greatest 
trust in stakeholder groups. 
 
5. METHOD 
5.1 Survey and respondents 
The British Social Attitudes Survey provides nationally representative data on adults 
aged 18 and over living in private households in Great Britain.  A module of questions 
assessed public attitudes to both modern genetic science (that is, to genetic technologies 
that have developed in the post genomic era, such as cloning) and to the scientists 
working in these areas. These questions were administered through face to face interview 
and self completion to approximately two thirds of the BSA sample, giving a total of 
3272 interviews, an overall response rate of 59 percent (Park, Curtice & Thomson et al.,. 
2004).  In our analysis, all percentages are based on data weighted for differences in the 
probability of individual and household selection. The bases shown in tables are 
unweighted. 
 
5.2 Measures 
Belief in public efficacy is based on the following item; ‘modern genetic science is so 
complex that public involvement is not realistic’. Responses were on a five-point scale 
from 1: ‘strongly agree’ to 5: ‘strongly disagree’. We are mainly interested in the people 
that indicate that public agreement is realistic and thus disagreement with this proposition 
is used as an indicator of a belief in public efficacy.  We are aware that using a single-
item indicator of public efficacy in our analysis is less than ideal, however it cannot be 
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avoided in this instance as the BSA survey was not designed specifically to measure 
public efficacy. To go at least some way towards validating the measure we note its 
relationship with other indicators of efficacy from a different section of the BSA survey 
that we might expect it to relate to
1
. Both items have been used to represent the concept 
of ‘political efficacy’ (Bromley, Curtice & Seyd, 2001) and are based on responses to the 
following propositions: ‘government is too complex to understand’ and ‘people like me 
have no say in government’. We also note the relationship between our belief in public 
efficacy measure with two indicators of active public engagement taken from the wider 
survey. A ‘government action index’ was derived from a series of items about whether or 
not respondents have undertaken action on a government issue they perceive to be unjust 
or harmful, such as writing to an Member of Parliament or signing a petition.  An 
‘organisational membership index’ is based on whether or not the respondent currently 
belongs to any voluntary or community group. 
Background characteristics were used to show the social composition of the efficacious 
public for modern genetic science and as control variables in our analysis of the 
relationships between public efficacy, trust and attitudes.   In addition to age and sex, we 
included an indicator of educational level based on highest reported qualification.  We 
assessed public attentiveness to issues concerning genes and genetics by combining four 
items that asked respondents the extent to which they had heard or read about such issues, 
talked about them or thought about them in the past few months.  The scores could vary 
from 1: ‘a great deal’ to 5: ‘not at all’.   The items were combined into a single summed 
scale of attentiveness (alpha=.78).  A series of six questions in the survey were designed 
to gauge people’s core values concerning science and nature; respondents chose between 
two anchoring statements concerning scientific progress and its role in the natural world
2
.  
These items were combined into a single values scale (alpha = .59
3
) where a high score 
was indicative of positive values towards scientific progress and intervention and a low 
score reflected values associated with the preservation of the natural order.  
 
                                                 
1
 Questions pertaining to political efficacy were not administered to the same sample of the BSA as our 
measure of public efficacy.  We therefore do not combine them for the main analysis presented here.   
2
 Items available from Park et al. (2004) 
3
 We recognise that the reliability of this measure is marginal 
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Public trust was based on responses to three items that distinguished different 
stakeholders as follows. 1: ‘Those in charge of new developments in genetic science 
cannot be trusted to act in society’s interests’. 2: ‘Rules set by government will not keep 
us safe from any risks linked to modern genetic science’. 3: ‘genetic scientists only tend 
to tell us what the people paying their wages want us to hear’.  Responses to these three 
items were given on a scale ranging from 1: ‘strongly agree’ to 5: ‘strongly disagree’. 
 
Public attitudes to modern genetic science were examined for three distinct genetic 
technologies: human cloning, gene therapy and the use of genetic databases.  
Respondents were asked four items about whether or not human cloning should be 
allowed for 1: organ transplants, 2: treatment for Parkinson’s Disease, 3: for someone in 
good health who wants to live longer and 4: for a infertile couple who cannot have a 
child.   Four items probed whether or not gene therapy should be allowed for the 
following purposes.  1: to lessen aggression or violence, 2: alter sexuality; 3: reduce 
chances of getting breast cancer: 4: determine the sex of an unborn baby.   For both 
human cloning and gene therapy, responses were scored from 1: ‘definitely not allowed’ 
to 4: ‘definitely allowed’.   Scored responses were summed into a single scale for 
attitudes to cloning (alpha=.82) and attitudes for gene therapy (alpha=.68) where a high 
score was indicative of a more permissive attitude.   Public attitudes towards use of 
genetic databases were assessed by 5 items about databases used for the following 
purposes, 1: illness and disease, 2: serious crimes; 3: ancestry; 4: health and life 
insurance; 5: employment.  Responses to each item were scored 1: ‘definitely not in 
favour’ to 4: ‘strongly in favour’.  Scored responses were summed into a single scale 
(alpha=.66) where a high score was consistent with a more favourable attitude towards 
use of genetic databases. 
 
6.  RESULTS 
6.1 Beliefs about public efficacy 
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A small majority (52 percent) agreed with the statement ‘modern genetic science is so 
complex that public involvement in policy decisions is not realistic’, thus failing to 
endorse the notion that members of the public think that they can play a meaningful role 
in this area of science.  Only 28 percent disagreed that the complexity of the science 
precluded any public contribution at policy level, thus displaying what we term belief in 
public efficacy (BPE).  As noted earlier, the survey was not specifically designed to 
address this issue, so in this exploratory work we must rely on this single measure to 
represent public efficacy.  However, we can explore how our measure of BPE relates to 
other questions in the survey pertaining to public perceptions of governance. 60% of the 
public are of the opinion that ‘government is too complex to understand’ and 65% agree 
that ‘people like me have no say in government’.  We also find small but significant 
correlations between these measures and the measure of BPE (Table 1), suggesting that 
these items relate to each other in the way that we might expect: people with a belief in 
public efficacy are both more likely to disagree that ‘government is too complex to 
understand’ (r = .22, p<.001) and  that ‘people like me have no say in government’(r = 
.11, p<.001).  The relationships between these three measures suggest that a low belief in 
public efficacy for genetic science mirrors a wider feeling of powerlessness around 
government for a significant proportion of the public.  In addition, the BPE item 
corresponds to indicators of active citizen engagement. We find that people with a belief 
in public efficacy are both more likely to have taken government action (r = .19, p<.001) 
and to be a member of an organisation (r.112, p<.001).  Overall, the consistency of these 
findings suggests that it is not unreasonable to proceed with using a single item measure 
of BPE in this exploratory analysis.  
As well as a lack of public efficacy for modern genetic science we find fairly low 
attentiveness among the public to issues of genes and genetics.  Only about one-quarter 
of the public rate themselves as having ‘a great deal’ or ‘quite a lot’ of interest in such 
issues, with approximately half having little or no interest (Table 2).  Although more than 
one-third had heard or read about the issues to a large extent over the past few months,  
more than 50 percent responded that they had talked or thought about the issues ‘not very 
much’ or ‘not at all’.   
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A logistic regression was conducted in order to identify significant predictors of 
BPE.  A linear regression was not conducted as the required assumptions of normality are 
problematic when using a single item outcome measure.  The outcome variable was thus 
recoded and had two levels:  those who agreed with the BPE item (scored as 0) versus 
those that disagreed or were undecided (scored as 1). Only those background variables 
that had a significant bi-variate association with the outcome variable were considered as 
predictors.    
The predictors were entered into the analysis simultaneously: age, gender, 
attentiveness to genes and genetics, educational levels and core values about science and 
nature.  A total of 1801 cases were included in the analysis.  The full model was 
significant (chi square = 197.1 df = 8 p < .001).  Table 3 gives the summary statistics and 
shows how important each predictor variable was independently of the effect of the 
others.  The final regression model indicates that those with a belief in public efficacy can 
be identified as male and with higher educational qualifications.  They tend to be those 
most attentive to this area of science.  We also find that people’s core values concerning 
the balance between science and nature are significantly associated with their belief about 
public involvement in genetic science; those who had values that can be broadly 
characterised as pro-nature and against scientific intervention were more likely to 
perceive high level public involvement as realistic. 
 
6.2 Public efficacy and trust 
A comparison of trust in stakeholder groups for modern genetic science is presented in 
Table 4.  This table shows that opinion differs according to the stated object of trust, with 
‘those in charge’ perceived more favourably than ‘genetic scientists’ on our attitude 
measures.   However, trust in genetic scientists is significantly higher for those with a 
belief in public efficacy (21 percent) compared with those who do not (13 percent) 
(correlation = .08, p<.001). The same pattern is evident for trust towards ‘those in charge’ 
where approximately 3 in 10 of those who believe in public efficacy express a trusting 
attitude, but this correlation did not reach significance. When the object of trust is the 
government, however, the opposite picture emerges. Here, a belief in public efficacy is 
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associated with significantly less trust in government rules to keep us safe from any risks 
linked to genetic science; 22 percent compared with 25 percent  (correlation = -.128, 
p<.001).  Thus, on what might be viewed as the most important object of trust with 
regard to public perceptions of genetic science, we find that those with an efficacious 
belief are less inclined to agree that government rules will offer public protection against 
risks associated with genetic science than those who reject public involvement. 
 
6.3 Public efficacy and attitudes towards genetic technologies   
Linear regression models were used to examine the impact of public efficacy on attitudes 
towards human cloning, gene therapy and the use of genetic databases (see Table 5). 
Attitudes towards human cloning and gene therapy are based on public perceptions about 
whether or not they should be allowed, whilst attitudes towards genetic databases use 
different response options to gauge the extent to which the public are in favour. The 
overall variance explained in each of the models although significant was small (the 
adjusted R
2
 values were .08, .08 and .09 respectively). However, after controlling for 
trust and background characteristics, our measure of belief in public efficacy was 
significantly associated with attitudes towards each of the three genetic technologies.  
This was not a positive effect; rather those with a belief in public efficacy had 
consistently less permissive attitudes towards human cloning (B= -.142, p<.001) and 
gene therapy (B= -.58, p<.001) and are less in favour of genetic databases (B=-.23, 
p<.001) than those who did not consider public involvement to be realistic.  This finding 
of more negative attitudes among the efficacious public contrasts with  the trust variables 
included in the models. Trust in ‘government rules’ and trust in genetic scientists was 
positively correlated with more permissive attitudes whilst trust in ‘those in charge’ made 
no significant contribution to any of the models.  Thus, the belief in public efficacy 
measure opposes trust in its relation to the permissiveness of attitudes to each of the three 
technologies. Rather, our results show that belief in public efficacy functions in a similar 
way to measures of attentiveness and education which also have a consistent negative 
association with attitudes.  Members of the public with higher levels of education, who 
are attentive to issues around genes and genetics or who have a belief in high level public 
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involvement, fail to endorse the future development of genetic technology in three key 
areas. 
 
7. DISCUSSION 
This study has focused on public efficacy for modern genetic science and its links with 
public trust and attitudes. Our first aim was to better understand the size and composition 
of the public that consider that public involvement around modern genetic science is 
realistic. Agreement with the proposition that this area of science is ‘too complex for 
public involvement in policy decisions’ was high, with less than 1 in 3 displaying a belief 
in public efficacy.  To some extent, this seems to reflect a broader picture of public 
disenfranchisement with their capacity to ‘make a difference’ in society through 
participation in government processes, as evidenced by similarly low levels of political 
efficacy in our analysis.   The relatively small proportion of people who did display a 
belief in public efficacy for modern genetic science were more likely to be those who 
were active citizens in their community and were most educated or familiar with, and 
interested in, the relevant issues. Although our data does not allow us to infer any causal 
relationship between public efficacy and attentiveness, it seems feasible to infer that 
people who are not conversant with the issues are more likely to reject a role for the 
public at large in this area of science whereas engagement with science or civic action 
more generally may reinforce positive beliefs about public efficacy, particularly if the 
outcome of such participation can be recognised as successful. An opposing argument, 
that the attentive public will know that genetic science is complex and thus might infer 
that a public role was not feasible, is not supported by our data.  A future challenge for 
policy makers is to reach out to a more socially inclusive public in order to avoid the 
pitfall of simply attracting people with the strongest, usually negative, opinions – a 
criticism levelled at the GM Nation? consultation.  Although exploratory in nature, our 
analysis suggests that increasing a sense of efficacy may be a valuable precursor to 
soliciting actual engagement.  
Our second aim was to better understand the relationship between public efficacy and 
trust towards relevant stakeholders in this area of science.  The nature of these 
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relationships bears further consideration although their strength was weak.  For one of 
our trust measures, the results are consistent with public efficacy co-existing with greater 
trust.  The efficacious public are more willing to trust in the independence of genetic 
scientists.  However, for trust associated with government rules, we find that people with 
a belief in public efficacy are less likely to agree that such rules will keep us safe from 
any risks associated with modern genetic science.  The term ‘any risks’ here is likely to 
be significant since agreement with this statement implies some sort of guarantee in the 
blanket protection of legislation and government which, given the uncertainties 
associated with this area of scientific development, it cannot provide.  In an investigation 
of how the public evaluate government with respect to key scientific developments, 
Poortinga & Pidgeon (2003a) found that general trust, incorporating notions of 
competence, care, fairness and openness was important, alongside scepticism toward a 
government perceived to be distorting the facts.  The authors report that different degrees 
of general trust co-exist with different levels of scepticism. Thus, people can be critical 
about the risks associated with a technology without rejecting the technology outright, a 
scenario they term ‘critical trust’. Consistent with this work, it may be more appropriate 
to view our finding of greater distrust of government among the efficacious public as 
indicative of a healthy dose of realism, a more critical trust in the legislative system to 
contain genetic technologies.   
 Our final aim was to examine how both trust and public efficacy map onto 
attitudes towards genetic technologies, net of other relevant factors.  Here, across three 
different applications with two different outcome measures, our results present a 
consistent picture of more permissive attitudes among those who had trusting attitudes 
towards genetic scientists and government rules.  Although this is consistent with the 
view that efforts to foster public trust may ‘pay off’ by softening public opinion, our 
results do not endorse the notion that greater public involvement will provide a route to 
public acceptance of genetic technologies.   We find that people who see a role for public 
involvement within this area of science are less likely than those who do not to agree 
human cloning and gene therapy should proceed and less likely to be in favour of human 
genetic databases.  In sum, public efficacy opposes trust in its relationship to attitudes.  
Our efficacy measure rather functions in a similar way to education and attentiveness to 
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genes and genetics, both of which were associated with more cautious attitudes across 
each domain of genetic technology. 
To some extent these results are counter intuitive.  As noted earlier, increasingly 
engaging the public is seen as one of the main routes to increasing public trust.  This in 
turn is considered as essential for increasing the acceptability of subsequent decisions.  
This exploratory analysis has rather suggested that considering public involvement to be 
realistic tended to be associated with less permissive attitudes to genetic technologies.  Of 
course, such a conclusion, stemming as it does from an exploratory analysis requires a 
range of both conceptual and methodological caveats.   
First of all, depending on how the notion of efficacy is conceptualised it might be argued 
that the relationship found here between a belief in public efficacy and attitudes to 
genetic technologies is to be expected.  Within the UK there is reason to believe that the 
public generally associates the government with a permissive attitudes to genetic 
technologies (Gaskell, Allum, Wagner & Kronberger et al.,  2004; Gaskell, Allum, 
Wagner & Hviid Nielsen et al., 2001).  If someone rather has a rather more negative 
attitude to such technologies it is entirely plausible that they would wish to be consulted 
about their development
4
.  However we would contend that there is an important 
difference between a desire for such involvement and believing that publics might 
actually be able to influence the course of decision making.  It is the latter variant that we 
believe is closer to the way in which belief in public efficacy is conceived of in this 
study.  It would seem eminently possible that you could wish to be involved in 
considering a matter which powerful groups supported – and you were against - whilst 
not believing that such involvement would make much difference.       
Secondly, it is worth noting that the conclusions that we have reached about the nature of 
the relationships between trust, attitudes to genetic technologies and a belief in public 
efficacy do not involve a consideration of actual involvement of publics in engagement 
processes that formally access and, at least purport to, take account of their beliefs.  Thus 
far we know little about the impact of such mechanisms on perceptions of collective 
efficacy.  The little we do know however might tend to suggest that, where there is little 
                                                 
4
 We are grateful to an anonymous reviewer for highlighting this point. 
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evidence of having made a difference, fatigue and scepticism – and presumably a 
weakened belief in public efficacy  -  are likely outcomes (Kasperson, 2000) .  The notion 
of BPE in this study has some links with the concept of ‘collective efficacy’ (Bandura, 
1998; Bandura, 2000; Fernández-Ballesteros, Díez-Nicolás & Caprara et al., 2002) which 
is currently emerging in relation to community, crime and health policy issues.  It would 
seem potentially valuable to broaden this consideration to the process and outcome of 
formal participation initiatives as well as, more generally, public appreciations of 
technological development.   Previous qualitative research in this area also suggests that 
it is important to consider the relationship between a sense of agency and expressions of 
public concern (Marris, Wynne & Simmons et al., 2001).  Their hypothesis is that 
expressions of public concern may be muted, not because concern is low but rather 
because a lack of agency may lead expressions of concern being seen as pointless.     
Moving on to methodological caveats we have endeavoured to be explicit about the 
shortcomings of our single item measure of BPE and of this largely exploratory analysis.  
In addition we recognise that the face validity of the BPE item might be considered 
limited:  it would be possible to agree that modern genetic science is so complex that 
public involvement is not realistic without feeling a lack of efficacy
5
. 
Notwithstanding these measurement problems we believe that the results of this work 
highlight an interesting way in which ongoing considerations of public perceptions of 
technological developments might be extended. Thus far trust has rightly assumed 
enormous prominence as an explanatory concept in relation to dissent and conflict over 
the development trajectory of a wide range of technologies. Consideration of the 
importance of a belief in public efficacy would potentially seem a valuable complement 
to this, and in particular to the recent work on critical trust (Poortinga & Pidgeon, 2003a; 
Walls, Pidgeon, & Weyman et al., 2004).  In order to do this and to explore the predictive 
power of a belief in public efficacy considerable work will be needed to refine the 
concept itself and to develop valid and reliable measures.  
On the basis of these data it would seem reasonable to at least question the nature of the 
link between increased public involvement and the legitimising of technological 
                                                 
5
 We are similarly grateful to a second anonymous reviewer for highlighting this. 
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development that engagement initiatives can be instrumentally predicated upon.  Rather, 
a belief that the public can make a difference may in fact be part of the forming the 
‘critical but involved’ citizenry that Poortinga & Pidgeon (2003a: p.971) suggest may be 
a desirable form of relationship between people and risk management institutions.    
In conclusion, this tentative introduction of the concept of a belief in public efficacy 
highlights potentially counter-intuitive relationships between trust, attitudes and a 
willingness to endorse public involvement in modern genetic science. Taken together, our 
data suggest that it is overly simplistic to view public involvement in decision making as 
a route to increase trust and the acceptability of potentially risky new technologies in our 
society.   
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Table 1.  Belief in public efficacy (BPE) by indicators of citizen engagement 
 
Correlation matrix: BPE No say in 
government 
Government 
too complex 
Government 
action index 
Organisational 
membership 
index 
BPE 1.00     
No say in government .11 *** 1.00    
Government too 
complex 
.22 *** .19 *** 1.00   
Government action 
index 
.19 *** .12 *** .24 *** 1.00  
Organisational 
membership index 
.11 *** .10 *** .14 *** .34 *** 1.00 
*** P<.001 
 
Source: British Social Attitudes Survey, 2003 
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Table 2:   Public attentiveness to issues about genes and genetics 
 
 
 
 Interest 
 
Heard or  
read about 
 
Talked 
about 
 
Thought 
about 
 
A great deal or quite a lot 24 36 14 21 
A small amount 25 30 27 26 
Not very much or not at all 51 33 59 53 
% 100 100 100 100 
Base: 3251 3251 3251 3251 
 
Source: British Social Attitudes Survey, 2003 
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Table 3: Predictors of public efficacy for modern genetic science 
 
 
 95% CI for exp b 
Included B Lower Exp b Upper 
Constant -1.34  .262  
Age in years -.005 .99 1.0 1.0 
Gender: female -.403*** .54 .67 .82 
Attentiveness to genes and genetics: 
high 
 .494*** 1.5 1.64 1.8 
Educational qualifications:      
None   1.00  
Other .412* 1.0 1.51 2.3 
O’level or equivalent .061 .69 1.06 1.6 
A’level or equivalent .912*** 1.67 2.49 3.7 
Higher 1.08*** 1.97 2.94 4.4 
Core values about science and  nature: 
pro scientific progress and intervention 
-.17 .76 .84 .94 
*p<.05; **p<.01; ***p<.001 
Chi square=197.1, df=8, p<.001 Cox&Snell R
2
= .10 Nagelkerke R
2
=.139 
 
Source: British Social Attitudes Survey, 2003 
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Table 4: Belief in public efficacy by trust in key stakeholder groups 
 
              Belief in Public Efficacy 
Trust: No Yes (BPE) All Spearman
Corr (Sig) 
Those in charge of new developments in 
genetic science cannot be trusted to act in 
society’s interests. 
 
% Disagree 
 
Base: 
 
 
 
 
24 
 
2153 
 
 
 
 
31 
 
846 
 
 
 
 
26 
 
2999 
 
 
 
 
.014 
(ns) 
Genetic scientists only tend to tell us what 
the people paying their wages want us to 
hear. 
 
% Disagree 
 
Base: 
 
 
 
 
13 
 
2176 
 
 
 
 
21 
 
844 
 
 
 
 
15 
 
3020 
 
 
 
 
.084 
(<.001) 
Rules set by government will keep us safe 
from any risks linked to modern genetic 
science. 
 
% Disagree 
 
Base: 
 
 
 
 
25 
 
2153 
 
 
 
 
22 
 
846 
 
 
 
 
24 
 
2999 
 
 
 
 
-.128 
(<.001) 
 
Source:  British Social Attitudes Survey, 2003 
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Table 5:  Regression coefficients
1 
of public efficacy and trust on attitudes towards genetic 
technologies 
 
Variables in model Human Cloning  
(allow) 
Gene Therapy 
(allow) 
Genetic Databases 
(in favour) 
Age (years) -.001 .012 -.001 
Gender: female -.11** -.64*** -.016 
Belief in public efficacy -.142*** -.58*** -.23*** 
Attentiveness (high) -.008*** -.136** -.044*** 
Trust in genetic scientists .071 .229 .021 
Trust in government rules .219*** .761*** .183*** 
Trust in those in charge .207*** .319*** .149*** 
Education: higher -.15*** -.603*** -.170*** 
    
N 1860 2906 2890 
F 21.1, p<.001 33.1,p<.001 35.9, p<.001 
Source:  British Social Attitudes Survey, 2003 
1 
Regression coefficients are unstandardised. 
 
  
